All breast cancer cell lines had at least 10-fold lower PTHR1 mRNA levels than MC3T3-E1 cells, which have a robust cAMP response to exogenous PTH and PTHrP treatment (24). The gene discussed is PTHLH; the disease is breast carcinoma.